Article
RHD variants in Flanders, Belgium. Van Sandt VS, Gassner C, Emonds MP, Legler TJ, Mahieu S, Körmöczi GF. Transfusion, 2015. [Citation]
Annotations by Allele
- DIII - partly characterized or subtypes not seperated: Prevalence
- DV - partly characterized or subtypes not separated: Prevalence
- RHCE*ce667T,697G,712G,733G,744C,787G,800A (ceHAR, ce.22): Prevalence
- RHD*1154C (weak D type 2): Prevalence
- RHD*307C (RHD*39): otherHaplotype
- RHD*307C (RHD*39): RH1
- RHD*307C (RHD*39): AbSpecificity
- RHD*307C (RHD*39): RH
- RHD*307C (RHD*39): Serology
- RHD*307C (RHD*39): Prevalence
- RHD*307C (RHD*39): RH
- RHD*307C (RHD*39): RH (polyclonal anti-G)
- RHD*307C (RHD*39): Density
- RHD*340T (weak D type 17): Prevalence
- RHD*446A (weak D type 5): Prevalence
- RHD*602G,607G,667G,744T,957A,1025C (DAR(T203A)): Prevalence
- RHD*809G (weak D type 1): Prevalence
- RHD*845A (weak partial D type 15): Prevalence
- RHD*848T (DHMi, RHD*19): Prevalence
- RHD*885T (weak partial D type 11): Prevalence
- RHD*8G (weak D type 3): Prevalence
- RHD*D-CE(3-6)-D (DVI type 3): Prevalence
- RHD*D-cE(4-5)-D (DVI type 1): Prevalence
- RHD*D-CE(4-6)-D (DVI type 2): Prevalence
- RHD*DAU - partly characterized or subtypes not separated: Prevalence
- RHD*RHD*D-CE(3-6)-D(1195A) (RHD*DVI type 3.2): RH1
- RHD*RHD*D-CE(3-6)-D(1195A) (RHD*DVI type 3.2): Prevalence
- weak D type 4 - partly characterized or subtypes not separated: Prevalence
- weak D type 4.2.x (DAR) - partly characterized or subtypes not separated: Prevalence